N. Tanaka

发表

Increased claudin-1 protein expression in hepatic metastatic lesions of colorectal cancer.

K. Shirouzu, Y. Akagi, Yousuke Oka, 2012, Anticancer research.

Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer

T. Nomura, S. Motoyama, Y. Akagi, 2014, Cancer Immunology Research.

The Usefulness of Serial Changes in Serum CA19-9 Levels in the Diagnosis of Pancreatic Cancer

H. Ueno, M. Ikeda, T. Okusaka, 2000, Pancreas.

Phase I study of a new cancer vaccine of ten mixed peptides for advanced cancer patients

Y. Heike, T. Sasada, S. Shichijo, 2016, Cancer science.

Minichromosome maintenance protein 7 is a risk factor for recurrence in patients with Dukes C colorectal cancer.

K. Shirouzu, Y. Akagi, T. Kinugasa, 2014, Anticancer research.

Utility of serum CA 19-9 monitoring in preoperative radiotherapy for pancreatic cancer.

Y. Itai, Y. Matsuzaki, K. Ohara, 2001, Hepato-gastroenterology.

Lateral lymph-node dissection for rectal cancer: meta-analysis of all 944 cases undergoing surgery during 1975-2004.

K. Shirouzu, Y. Akagi, Yousuke Oka, 2013, Anticancer research.

Amphiregulin is a prognostic factor in colorectal cancer.

K. Shirouzu, S. Miyamoto, Y. Akagi, 2012, Anticancer research.

Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection.

H. Ueno, M. Sakamoto, M. Ikeda, 2001, Hepato-gastroenterology.

Virchow lymph node metastatic recurrence of sigmoid colon cancer with severe lymph node metastases successfully treated using systemic chemotherapy combined with radiotherapy.

K. Shirouzu, Y. Akagi, T. Kinugasa, 2013, Anticancer research.